|
|
Volumn 96, Issue 1, 2005, Pages 181-182
|
|
The era of ESSTIs is slowly approaching?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DAPOXETINE;
PHOSPHODIESTERASE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SELECTIVITY;
EJACULATION;
EJACULATION DISORDER;
HUMAN;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
SEROTONIN UPTAKE;
SIDE EFFECT;
BENZYLAMINES;
EJACULATION;
HUMANS;
IMPOTENCE;
MALE;
MEMBRANE GLYCOPROTEINS;
MEMBRANE TRANSPORT MODULATORS;
MEMBRANE TRANSPORT PROTEINS;
NAPHTHALENES;
NERVE TISSUE PROTEINS;
SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;
|
|
EID: 21744456774
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1464-410X.2005.05659.x Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
